Weidong Lu, MB, MPH, Ph.D.
Weidong Lu, MB, MPH, PhD is Instructor of Medicine at Harvard Medical School and the Oncology Acupuncture Team Leader at Leonard P. Zakim Center, Dana-Farber Cancer Institute (DFCI), a U.S. top cancer hospital and a principal teaching affiliate of Harvard Medical School. He created and established the Oncology Acupuncture Specialty at DFCI. In addition to his clinical practice, he is a principal investigator conducting NIH-funded acupuncture clinical trials in symptom management for cancer patients. He is the first recipient of the Bernard Osher Foundation/ The National Center for Complementary and Alternative Medicine (NCCAM ) CAM Practitioner Research Career Development Award ( K01 ). He recently created the Chinese Medicine Research Initiative Program at DFCI to expand his research efforts in cancer care and promote US-China academic exchange.
Dr. Lu is a member of the Research Committee of the Society for Integrative Oncology, and a member of the American Society of Clinical Oncology. He lectures at the New England
School of Acupuncture, a part of MCPHS University (formerly Massachusetts College of Pharmacy and Health Sciences) as Professor of Chinese Medicine. He also chairs the Committee On Acupuncture at the Massachusetts Board of Registration in Medicine. His work has been the topic of many mainstream US news media reports , including Boston Channel 5 (WCVB-TV); New England Cable News (NECN), and the US Cable News Network (CNN).
He holds a M.B. from Zhejiang Chinese Medical University, a MPH from Harvard School of Public Health and a PhD from Beijing University of Chinese Medicine. He combines his unique training in both Eastern and Western medicine to bring Traditional Chinese Medicine and acupuncture into the mainstream of Western society. His personal motto is: “Bring Medicines Together!”
